Healthcare and pharmaceuticals
Spatial Global has been serving the UK healthcare, pharmaceutical and medical device/equipment sectors since the late 1980s – initially supporting companies like Boots Healthcare, Boots Pharmaceuticals and BASF-Knoll. Today we manage the worldwide movement of controlled and prescription drugs, plus temperature-controlled pharmaceutical products, for a wide range of customers.
HOLIDAY MEDICATIONS SERVICE
A notable contract in this sector is Spatial's award-winning holiday medications service – which commenced in 1998 and has been running ever since. This highly tailored service involves the delivery of dialysis products, medications, equipment and enteral nutrition to individual patients at holiday destinations around the world – resorts, campsites, cruise ships, hotels, villas, etc. Because even the most basic logistics infrastructure is often absent in such locations – and despite an environment where failure is not an option – we have had to take a highly creative approach to the supply chain.Read more...
We also handle the worldwide movement of limited/low quantity (LQ) dangerous goods, plus products for clinical trials and samples. We manage return import shipments, and support a variety of time-specific deliveries, including onboard couriers.
As online ordering and direct-to-consumer deliveries continue to grow, today's healthcare supply chains must be tailored, agile and cost-efficient. Mid-sized logistics companies like Spatial Global are ideally suited to providing the high degree of customisation necessary, as they are not limited to working within any particular corporate model. At Spatial we adjust our services to meet every aspect of our customers' requirements and – unlike most of the giant providers – we also offer an executive single point of contact.
Long-term relationships with customers allow us to develop optimal routes around the world. The strength of our partnerships with overseas suppliers is key to our success, as they continually communicate detailed local requirements and developments back to us.
No news stories found.